Preclinical Safety Evaluation of Biopharmaceuticals

Discover the essential guide for biopharmaceutical safety with Preclinical Safety Evaluation of Biopharmaceuticals, published by John Wiley & Sons Inc. This comprehensive hardback, released in 2008, spans an impressive 1072 pages and is designed for researchers and professionals in the field. The book provides in-depth insights into the design, implementation, and evaluation of preclinical toxicology studies specific to biopharmaceuticals. It thoroughly explores the practices of preclinical safety evaluation, including critical aspects such as animal testing and toxicity screening for biotechnology drugs. Additionally, it addresses important regulatory considerations in the United States, making it an invaluable resource for anyone involved in the development and assessment of biopharmaceuticals. Enhance your understanding and ensure compliance with this authoritative text.